
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations From the American College of Gastroenterology and Society of Abdominal Radiology</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations From the American College of Gastroenterology and Society of Abdominal Radiology</strong></summary>
            <div>
                <ul><li>Journal: The American Journal of GASTROENTEROLOGY</li><li>Publication Date: MARCH 2024</li><li>DOI: 10.14309/ajg.0000000000002631</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What is the minimum bleeding rate detectable by modern multidetector CT Angiography (CTA)?</li><li>2. For a 99mTc-RBC scan, a Time to Positive (TTP) of less than how many minutes is associated with a significantly higher diagnostic yield on subsequent catheter angiography?</li><li>3. What is the technical success rate of embolization for acute lower GI bleeding, and what is the approximate re-bleeding rate?</li><li>4. In adults, what is the reported sensitivity of a Meckel scan for detecting a Meckel diverticulum, and how does it compare to the sensitivity in children?</li><li>5. What is the preferred oral contrast agent for CT Enterography (CTE) when evaluating for suspected small bowel bleeding, and why?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Overview of GI Bleeding</strong></summary>
            <div>
                <ul><li>GI bleeding is the most common GI diagnosis → hospitalization in the US.</li><li>Prompt diagnosis &amp; treatment are critical to improve outcomes.</li></ul>
                
        <details>
            <summary><strong>Upper GI Bleeding (UGIB)</strong></summary>
            <div>
                <ul><li>Definition: Bleeding from esophagus, stomach, or duodenum.</li><li>Accounts for ≈80% of bleeding events.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Lower GI Bleeding (LGIB)</strong></summary>
            <div>
                <ul><li>Definition: Bleeding distal to the ileocecal valve.</li><li>Accounts for ≈15%–30% of all GI bleeding events.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Small Bowel (Midgut) Bleeding</strong></summary>
            <div>
                <ul><li>Definition: Bleeding between the ligament of Treitz &amp; the ileocecal valve.</li><li>Accounts for ≈5%–10% of GI bleeding events.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Diagnostic Testing in Overt LGIB</strong></summary>
            <div>
                <ul><li>Evaluation of active bleeding originating from the colon.</li></ul>
                
        <details>
            <summary><strong>CT Angiography (CTA)</strong></summary>
            <div>
                <ul><li>Primary goals: Determine location &amp; assess intensity of bleed.</li><li>Secondary goal: Identify cause of bleeding.</li></ul>
                
        <details>
            <summary><strong>Technique</strong></summary>
            <div>
                <ul><li>Multiphase CT technique required to confirm contrast extravasation.</li><li>- Noncontrast phase: Identifies high-attenuation material that can mimic bleeding.</li><li>- Late arterial phase: ≈25–35 seconds post-injection.</li><li>- Portal venous (60-70s) or late venous (70-90s) phase.</li></ul>
                
        <details>
            <summary><strong>Key Technical Points</strong></summary>
            <div>
                <ul><li>Bolus tracking is suitable for patients w/ varying cardiac outputs.</li><li>Oral contrast should be avoided → delays scanning &amp; can obscure bleeding.</li><li>Post-processed 3D images help guide subsequent angiography.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Technique</strong></summary>
            <div>
                <ul><li>1. Unenhanced images (conventional or virtual) should be acquired in all cases.</li><li>2. Images should be acquired during a late arterial phase AND a portal venous or delayed phase.</li><li>3. No oral contrast should be administered.</li><li>4. 3D CTA images can be generated to guide subsequent conventional angiography.</li><li>5. Dual-energy CT may be used to improve visibility of contrast extravasation.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Performance Data</strong></summary>
            <div>
                <ul><li>Highly sensitive (85%–90%), specific (92%), and accurate (94%–95%).</li><li>Can detect bleeding rates as low as 0.1 mL/min w/ multidetector CT.</li><li>Larger extravasation volumes on CTA → associated w/ higher transfusion needs &amp; need for hemostatic therapy.</li></ul>
                
        <details>
            <summary><strong>Prognostic Value</strong></summary>
            <div>
                <ul><li>A negative CTA is associated with a ↓ rate of rebleeding and need for intervention.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Advantages</strong></summary>
            <div>
                <ul><li>Noninvasive, short examination time, widely available.</li><li>Well-suited for hemodynamically unstable patients.</li><li>Provides a vascular &amp; enteric anatomical roadmap for planning subsequent procedures (endoscopic, IR, or surgical).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Limitations</strong></summary>
            <div>
                <ul><li>Requires IV contrast administration.</li><li>Involves ionizing radiation, which can be higher than standard CT due to multiple phases.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>1. Should be performed as the first diagnostic study in hemodynamically unstable patients.</li><li>2. Could be considered the first-line study in stable patients w/ high suspicion of active bleeding.</li><li>3. Not indicated as a first-line test in stable patients where bleeding has subsided.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Nuclear Medicine: 99mTc-RBC Scan</strong></summary>
            <div>
                <ul><li>Preferred radiopharmaceutical: 99mTc-labeled red blood cells (99mTc-RBCs).</li><li>Long intravascular half-life allows continuous imaging for several hours.</li></ul>
                
        <details>
            <summary><strong>Technique</strong></summary>
            <div>
                <ul><li>Dynamic imaging for a minimum of 1 hour.</li><li>Reviewing images in 10-15 minute sequences may ↓ time to catheter angiography.</li><li>Single-photon emission CT (SPECT)/CT can clarify indeterminate findings.</li></ul>
                
        <details>
            <summary><strong>Consensus Recommendations: Technique</strong></summary>
            <div>
                <ul><li>1. The in vitro RBC labeling method is preferred due to highest labeling efficiency.</li><li>2. Imaging should be continued for 1 hour if no bleeding is detected.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Performance Data</strong></summary>
            <div>
                <ul><li>Sensitivity: 93%; Specificity: 95%.</li><li>Can detect bleeding rates as low as 0.1 mL/min (clinical) or 0.04 mL/min (experimental).</li><li>Time to positive (TTP) &lt; 9 minutes → associated w/ a 6x greater likelihood of a positive catheter angiography (CA).</li><li>TTP &gt; 9 minutes → accurately predicted negative CA in 94% of patients.</li></ul>
                
        <details>
            <summary><strong>Comparison to CTA</strong></summary>
            <div>
                <ul><li>One study showed 99mTc-RBC scans had lower accuracy (55.4%) vs CTA (96%).</li><li>SPECT/CT may improve localization accuracy compared to planar imaging alone.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Advantages</strong></summary>
            <div>
                <ul><li>High sensitivity for intermittent bleeding due to prolonged imaging time (up to 24 hours).</li><li>Lower radiation dose compared to CTA.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Limitations</strong></summary>
            <div>
                <ul><li>Only for hemodynamically stable patients.</li><li>Long preparation &amp; imaging times.</li><li>Incorrect localization reported in 10%–33% of cases.</li><li>Labeling efficiency can be ↓ by low hematocrit, recent transfusions, hemoglobinopathies, and some medications (e.g., heparin).</li></ul>
                
        <details>
            <summary><strong>Common Pitfalls</strong></summary>
            <div>
                <ul><li>False positives can occur from physiologic activity or other conditions:</li><li>- Ureters, penile activity</li><li>- Splenosis, pancreatic pseudocysts</li><li>- Non-enteric bleeding/hematoma</li><li>*True GI bleeding changes in intensity and moves over time.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>1. Perform in a hemodynamically stable patient with:</li><li>- Evidence of ongoing LGIB</li><li>- Negative evaluation with colonoscopy</li><li>- CTA is negative, contraindicated, or not available.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Catheter Angiography (CA)</strong></summary>
            <div>
                <ul><li>Invasive procedure for diagnosis &amp; treatment (embolization).</li><li>Most commonly performed for unstable patients w/ active LGIB who are not candidates for endoscopy.</li></ul>
                
        <details>
            <summary><strong>Technique</strong></summary>
            <div>
                <ul><li>Ideally performed after CTA to identify the vessel territory.</li><li>Access via common femoral or left radial artery.</li><li>Superselective angiogram of the vasa recta is performed, followed by embolization.</li></ul>
                
        <details>
            <summary><strong>Embolization Goal &amp; Agents</strong></summary>
            <div>
                <ul><li>Goal: ↓ blood flow to achieve hemostasis while maintaining collateral perfusion to prevent bowel ischemia.</li><li>Agents: Microcoils or glue (N-butyl 2-cyanoacrylate).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Technique</strong></summary>
            <div>
                <ul><li>1. Can be performed through common femoral or radial artery access.</li><li>2. Use permanent agents (microcoils, glue) to embolize vasa recta at the bleeding site.</li><li>3. Embolization should NOT be performed without active extravasation on angiography.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Performance Data</strong></summary>
            <div>
                <ul><li>Technical success of embolization: &gt;95%.</li><li>Recurrent bleeding may occur in up to 25% of patients.</li><li>Glue embolization may have a better impact on recurrent bleeding rates than microcoils.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advantages</strong></summary>
            <div>
                <ul><li>Ability to both diagnose and definitively treat at the same time.</li><li>High technical success rate with relatively low rate of recurrent bleeding.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Limitations</strong></summary>
            <div>
                <ul><li>Invasive procedure with risks: hematoma, dissection, AV fistula.</li><li>Bowel ischemia risk: up to 10% (most asymptomatic), more common with glue.</li><li>Only effective if bleeding is active at the time of the procedure.</li><li>Requires iodinated contrast and significant radiation exposure.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>1. If CTA is negative for GI bleeding, CA is not indicated in most cases.</li><li>2. In unstable patients w/ active extravasation on CTA, CA w/ embolization can be used as the primary treatment.</li><li>3. Provocative CA can be performed for recurrent intermittent LGIB if all other modalities have failed.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Diagnostic Testing in Suspected Small Bowel Bleeding</strong></summary>
            <div>
                <ul><li>Evaluation of bleeding originating between the ligament of Treitz and the ileocecal valve.</li></ul>
                
        <details>
            <summary><strong>CT Enterography (CTE)</strong></summary>
            <div>
                <ul><li>Designed to optimize evaluation of the small bowel wall.</li><li>Requires ingestion of a large volume (≈1.5 L) of neutral oral contrast to distend the bowel.</li></ul>
                
        <details>
            <summary><strong>Technique</strong></summary>
            <div>
                <ul><li>Neutral oral contrast is preferred: hyperenhancing lesions (vascular, inflammatory, neoplastic) are more conspicuous against low-density fluid.</li><li>IV contrast is required.</li><li>Can be single-phase or multiphase.</li></ul>
                
        <details>
            <summary><strong>Phase Selection</strong></summary>
            <div>
                <ul><li>Single-phase (enteric or portal venous): Adequate for inflammation &amp; most masses.</li><li>Multiphase (arterial + enteric/portal venous ± delayed): Improves detection &amp; characterization of vascular lesions.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Technique</strong></summary>
            <div>
                <ul><li>1. Use multiphase technique in patients &gt;40 years old (vascular lesions are common).</li><li>2. Multiphase CTE should include at least arterial, and enteric or portal venous phases.</li><li>3. &#x27;Multiphase CTE&#x27; is the recommended term for this indication.</li><li>4. Single phase is adequate for inflammatory conditions (Crohn&#x27;s, radiation enteritis) &amp; most malignancies.</li><li>5. Administer neutral enteric contrast in divided doses starting 1 hour before CTE.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Performance Data</strong></summary>
            <div>
                <ul><li>Data is heterogeneous; most studies include patients with overt bleeding.</li><li>Occult bleeding: Sensitivity 30.9%, Specificity 69.4%.</li><li>Overt bleeding: Sensitivity 39.5%, Specificity 73.9%.</li><li>Diagnostic yield is lower in occult bleeding (0%–33.3%) vs. overt bleeding (22.4%–66.7%).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advantages</strong></summary>
            <div>
                <ul><li>Greater sensitivity for small bowel masses, especially mural-based ones.</li><li>Allows visualization of extraintestinal structures (mesentery, vessels).</li><li>Can be first-line study if risk of video capsule retention is high (e.g., prior surgery, Crohn&#x27;s disease).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Limitations</strong></summary>
            <div>
                <ul><li>Use of ionizing radiation and IV contrast.</li><li>Neutral oral contrast may theoretically dilute active contrast extravasation.</li><li>Incompletely distended bowel may obscure or mimic pathology.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>1. Perform in stable patients w/ ongoing suspected small bowel bleeding after negative EGD/colonoscopy.</li><li>2. If bleeding is brisk w/ hemodynamic instability, perform CTA instead of CTE.</li><li>3. First-line test if patients are at ↑ risk for video capsule retention.</li><li>4. First-line study if small bowel neoplasm is suspected.</li><li>5. Can be performed if capsule endoscopy is negative but suspicion for ongoing bleeding remains.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Meckel Scan</strong></summary>
            <div>
                <ul><li>Uses IV 99mTc pertechnetate, which accumulates in ectopic gastric mucosa found in a Meckel diverticulum.</li></ul>
                
        <details>
            <summary><strong>Performance Data</strong></summary>
            <div>
                <ul><li>Less sensitive in adults (63%) compared to children (85%).</li><li>Most symptomatic Meckel diverticula are found in children and young adults.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>1. Can be considered for unexplained intermittent GI bleeding in children &amp; adolescents after negative endoscopic evaluation and cross-sectional imaging.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Diagnostic Testing in Nonvariceal UGIB</strong></summary>
            <div>
                <ul><li>Evaluation of bleeding from the esophagus, stomach, or duodenum not related to varices.</li></ul>
                
        <details>
            <summary><strong>CT Angiography (CTA)</strong></summary>
            <div>
                <ul><li>Paucity of data compared to LGIB.</li><li>May be helpful if endoscopy cannot identify the source or is not feasible.</li></ul>
                
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>In the setting of ongoing bleeding, CTA can be considered:</li><li>- If patient is not suitable for EGD or no in-house emergency GI coverage is available.</li><li>- After a negative EGD or if EGD is unable to identify the bleeding site.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Catheter Angiography (CA)</strong></summary>
            <div>
                <ul><li>Indicated when endoscopy is unsuccessful in achieving hemostasis or for recurrent bleeding.</li><li>May be first-line treatment in select cases (e.g., hepatic pseudoaneurysm).</li></ul>
                
        <details>
            <summary><strong>Technique</strong></summary>
            <div>
                <ul><li>Target the bleeding vessel identified on prior imaging/endoscopy.</li><li>Interrogate both celiac and superior mesenteric arteries.</li><li>Superselective embolization is preferred; endoscopic clips can help guide localization.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Outcomes</strong></summary>
            <div>
                <ul><li>Technical success rate: up to 95%.</li><li>Clinical success rate: ≈67%.</li><li>Rebleeding rate: ≈33% on the first attempt.</li><li>Complication rate: up to 10% (access site issues, renal damage, non-target embolization).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Consensus Recommendations: Role/Indications</strong></summary>
            <div>
                <ul><li>1. Indicated when an EGD is unsuccessful in achieving initial hemostasis.</li><li>2. Indicated if the patient experiences recurrent bleeding after a successful initial EGD and a repeat EGD is unsuccessful or not recommended.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
